Trials / Terminated
TerminatedNCT02138578
Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma
A Phase II Randomized Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for the Treatment of Localized Renal Cell Carcinoma (RCC)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- University of Michigan Rogel Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess whether Stereotactic Body Radiation Therapy (SBRT) can provide comparable local control, with similar or improved toxicity rates compared to Radio Frequency Ablation (RFA) when treating small renal cell carcinomas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | SBRT | |
| RADIATION | RFA |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-12-01
- Completion
- 2017-02-01
- First posted
- 2014-05-14
- Last updated
- 2017-11-07
- Results posted
- 2017-11-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02138578. Inclusion in this directory is not an endorsement.